Search

everythinglearnresearchcommunity

for

Search:↓

Doctors should check for serious tumor causes of high androgen levels in postmenopausal women and more research is needed on this condition.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Removing a testosterone-producing tumor cured a woman's sleep apnea and other symptoms.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Treatment balancing hormones stopped hair loss in most women with androgenetic alopecia.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Treat hirsutism in premenopausal women with oral contraceptives and consider additional treatments if needed.

The treatment successfully lowered testosterone levels and reduced symptoms.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.